《MedRixv,2月28日,(第2版更新)Interventions targeting air travellers early in the pandemic may delay local outbreaks of SARS-CoV-2》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-29
  • Interventions targeting air travellers early in the pandemic may delay local outbreaks of SARS-CoV-2

    Samuel J Clifford, Carl A B Pearson, Petra Klepac, Kevin Van Zandvoort, Billy J Quilty, CMMID COVID-19 working group, Rosalind M Eggo, Stefan Flasche

    doi: https://doi.org/10.1101/2020.02.12.20022426

    Abstract

    Background: We evaluated if interventions aimed at air travellers can delay establishment of a SARS-CoV-2 outbreak in a previously unaffected country. Methods: For countries with no sustained SARS-CoV-2 transmission and with no shared border with affected regions we simulated arriving infected air travellers. We assessed the effectiveness of syndromic screening at departure and/or arrival & traveller sensitisation to the COVID-2019-like symptoms with the aim to trigger rapid self-isolation and reporting on symptom onset to enable contact tracing.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.02.12.20022426v2
相关报告
  • 《MedRixv,2月13日,Interventions targeting air travellers early in the pandemic may delay local outbreaks of SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-14
    • Interventions targeting air travellers early in the pandemic may delay local outbreaks of SARS-CoV-2 Samuel J Clifford, Petra Klepac, Kevin Van Zandvoort, Billy J Quilty, CMMID nCoV working group, Rosalind M Eggo, Stefan Flasche doi: https://doi.org/10.1101/2020.02.12.20022426 Abstract Objectives: To determine if interventions aimed at air travellers can delay establishment of a SARS-CoV-2 outbreak in a previously unaffected country. Design: Simulation study Setting: Countries with no sustained SARS-CoV-2 transmission and with no shared border with affected regions Participants: Infected air travellers Interventions: Syndromic screening at departure and/or arrival & traveller sensitisation to the COVID-2019-like symptoms with the aim to trigger rapid self-isolation and reporting on symptom onset. Main outcome measures: The achievable delay until a major local outbreak is likely to occur Results: We evaluated traveller sensitisation effectiveness in reducing the number of secondary cases of 30, 50 and 70%, and assumed either 1, 10, or 100 infected travellers per week. Early in the outbreak when only few infected travellers arrive, traveller sensitisation can delay a major outbreak in a previously unaffected region. For 50% sensitisation effectiveness, and assuming 1 infected traveller per week, we find that in 75% of simulations the outbreak is delayed by at least 11 days (97.5% of simulations: at least 7 days). The possible delay decreases rapidly for more travellers, lower effectiveness of sensitisation, higher R0 or lower heterogeneity thereof. Syndromic traveller screening at departure and/or arrival can further enhance outbreak delays. In combination with sensitisation, syndromic screening can delay an outbreak substantially longer. In 75% of simulations we find an outbreak delay of at least 111 days (97.5% of simulations: at least 23 days) for 1 infected traveller per week and at least 9 days (97.5% of simulations: at least 4 days) for 10 infected travellers per week. Conclusion: Air-traveller targeted interventions, particularly in combination, can delay local SARS-CoV-2 outbreaks in the magnitude of a few weeks to potentially even months if the number of infected travellers remains low. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《MedRixv,2月22日,(第2版更新)Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-23
    • Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Jing Liu, Sumeng Li, Jia Liu, Boyun Liang, Xiaobei Wang, Hua Wang, Wei Li, Qiaoxia Tong, Jianhua Yi, Lei Zhao, Lijuan Xiong, Chunxia Guo, Jin Tian, Jinzhuo Luo, Jinghong Yao, Ran Pang, Hui Shen, Cheng Peng, Ting Liu, Qian Zhang, Jun Wu, Ling Xu, Sihong Lu, Baoju Wang, Zhihong Weng, Chunrong Han, Huabing Zhu, Ruxia Zhou, Helong Zhou, Xiliu Chen, Pian Ye, Bin Zhu, Shengsong He, Yongwen He, Shenghua Jie, Ping Wei, Jianao Zhang, Yinping Lu, Weixian Wang, Li Zhang, Ling Li, Fengqin Zhou, Jun Wang, Ulf Dittmer, Mengji Lu, Yu Hu, Dongliang Yang, Xin Zheng doi: https://doi.org/10.1101/2020.02.16.20023671 Abstract Background: The dynamic changes of lymphocyte subsets and cytokines profiles of patients with novel coronavirus disease (COVID-19) and their correlation with the disease severity remain unclear. Method: Peripheral blood samples were longitudinally collected from 40 confirmed COVID-19 patients and examined for lymphocyte subsets by flow cytometry and cytokine profiles by specific immunoassays. Findings: Of the 40 COVID-19 patients enrolled, 13 severe cases showed significant and sustained decreases in lymphocyte counts but increases in neutrophil counts than 27 mild cases. Further analysis demonstrated significant decreases in the counts of T cells, especially CD8 + T cells, as well as increases in IL-6, IL-10, IL-2 and IFN-γ levels in the peripheral blood in the severe cases compared to those in the mild cases. T cell counts and cytokine levels in severe COVID-19 patients who survived the disease gradually recovered at later time points to levels that were comparable to those of the mild cases. Moreover, the neutrophil-to-CD8+ T cell ratio (N8R) were identified as the most powerful prognostic factor affecting the prognosis for severe COVID-19. Conclusion: The degree of lymphopenia and a proinflammatory cytokine storm is higher in severe COVID-19 patients than in mild cases, and is associated with the disease severity. N8R may serve as a useful prognostic factor for early identification of severe COVID-19 cases. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.